ABSTRACT In a prospective evaluation of percutaneous Trucut needle biopsy for localised intrathoracic lesions in 89 patients histological specimens were obtained in 81. Malignancy was diagnosed in 66 cases. Subsequently definitive histological reports were available in 18 of these patients with complete concordance of malignant cell type. Sixteen patients had non-malignant histological appearances, which were later confirmed objectively in six. In three patients there was no follow up information, but in the remainder the clinical course was entirely consistent with the histological appearances of the biopsy specimens. Adequate specimens were obtained from only two of the five lesions less than 2 cm in diameter. Lesions deeper than 8 cm from the site of biopsy were associated with significantly more haemorrhagic complications than more superficial lesions. Comparison with other series indicates that Trucut needle biopsy which produces histological specimens has greater diagnostic accuracy than cytological techniques for both malignant and non-malignant localised lesions. It is concluded that this technique has a definite place in the investigation of this common problem in carefully selected patients provided that strict attention is paid to the details of the technique.
Leyden' is credited with the first diagnostic pulmonary needle aspiration in a patient with pneumonia, but Menetrier2 probably performed the first cutting needle biopsy for histological diagnosis. Since 1959 several groups have reported on the diagnostic use of percutaneous cutting needle biopsy in the diagnosis of lung disease.3'2 All but three of these studies346 included patients with diffuse lung disease as well as patients with localised lesions, and most if not all were retrospective surveys. Recent reviews have concluded that cutting needles should no longer be used because the incidence of complications (such as haemorrhage, pneumothorax, and air embolism) and mortality rate are unacceptably high.'3 " Review of the published series, however, suggests that most of the serious complications occurred in patients with diffuse or fibrotic lung disease-a point emphasised by Aronvitch et al, 6 Youmans et al, '°and Zavala and Bedell.' I Furthermore, in the earlier series (where complication rates Recently techniques of lung "biopsy" which produce cytological specimens have gained popularity.
These include aspiration and use of the Nordenstrom screw or one of its variants. The advantage claimed for this technique is that it is safer, but the disadvantages include the requirement of an expert cytopathologist and the fact that non-malignant and some malignant lesions are difficult to categorise.
For these reasons we have conducted a prospective study of the value of percutaneous biopsy with a Trucut needle in patients with localised intrathoracic lesions. Our results indicate that this technique is not as dangerous as recent reviews have suggested. The complication rate is similar to the rates reported for aspiration and Nordenstrom screw techniques and the diagnostic yield is very high.
Methods

THE PATIENTS
From June 1978 to July 1983 89 patients, aged 23-81 (mean 62) years, had percutaneous lung biopsy. Details of their age and sex; site; size and depth of lesion assessed from the chest radiograph; 494 the presumed diagnosis; results of spirometry; presence or absence of radiographic evidence of emphysema; histological diagnosis; and complications were recorded on a standard form. Most had a suspected lung tumour. Before biopsy, all cases were discussed by a radiologist, a thoracic physician, and usually a thoracic surgeon. Patients had posteroanterior and lateral chest radiographs and in most cases anteroposterior or lateral tomograms to localise the lesion. Before biopsy two patients had pulmonary angiography to exclude aneurysm and arteriovenous malformation, one aortography to exclude an aneurysm, and one ultrasound examination to ensure that the "mass" was not a Bochdalek hernia. Spirometry was performed with a Vitalograph dry spirometer and all patients had a clotting screen and were blood grouped. Thirty two patients had had bronchoscopy with negative results.
Absolute contraindications to the procedure included any blood clotting abnormality, inability to withstand a pneumothorax, pulmonary hypertension or an uncooperative patient.578"
TECHNIQUE OF BIOPSY
The patients had their biopsies in the early afternoon after a normal breakfast but no lunch. Most received no premedication. In the radiology theatre, the patient was usually positioned by means of single plane screening so that the vertical distance between the chest wall and the " mass" was the shortest possible compatible with a view of the lesion. The patient was then made comfortable in this position and 0 5 % lignocaine was infiltrated into the skin and underlying tissues. Whenever the operator felt the anaesthetic needle approaching the pleura he asked the patient to stop breathing to avoid a pleural tear. The distance between the skin surface and the proximal edge of the mass was measured from the radiographs and this distance was marked on the Trucut needle with plastic Spencer Wells forceps or with a finger. The Trucut needle was introduced through a small scapel incision and advanced into the lung in a vertical direction to the appropriate depth. During this time the patient was once again asked not to breathe. The position of the needle was then checked on the image intensifier screen. In difficult cases the needle was actually introduced into the lesion under direct vision. The mass could often be felt as a solid resistance when the tip of the needle entered it. Confirmation that the tip of the needle lay in the mass was obtained by parallax during respiration and by rotating the patient gently with the needle in place. The inner stylet of the Trucut needle was then advanced fully and the position usually checked again. The cutting sheath of the needle was advanced, the biopsy specimen obtained, Clinical details and outcome in the four patients with unhelpful histology and in the three from whom no tissue was obtained are given in table 2. Figure 2 shows the distribution of the sizes of the lesions as seen on the chest radiograph. Eighty one (89%) were 2-10 cm in maximum diameter. The biopsy produced diagnostic material from only two of the five lesions that were less than 2 cm in diameter.
The distribution of the depths of the lesions from the biopsy site is shown in figure 3 . In 73% of cases the lesion lay 3-8 cm from the body surface. Nineteen patients had lesions at a depth of 9 cm or more. The biopsy specimen was diagnostic in 17 of these but eight developed a pneumothorax (requiring an intercostal tube in one) and eight had haemoptysis, which was large or severe in four.
Twenty three patients developed a pneumothorax but only four required intercostal tube drainage. Demonstrable haemorrhage occurred in 17 patients. In 11 this was a small amount of blood spitting (including blood streaking of the sputum) or a small increase in the size of the mass on the chest radiograph. In five patients 50-150 ml of blood were expectorated. A further patient developed a large presumed haemothorax after the biopsy. She refused further diagnostic procedures and was the only patient who required a blood transfusion. The difference between the frequency of large haemorrhages when the lesion was 9 cm deep or more and and intercostal tubes were required in up to 5-5%.
as more superficial was significant (X2 = Haemoptysis was infrequently reported (in up 0-05). The incidence of pneumothoraces to 7-1% of cases in the questionnaire survey'2) those requiring an intercostal tube) was and serious haemorrhage was reported only in the -antly related to the depth of the lesion or questionnaire survey (0-5%). One death was 11,.
reported in the questionnaire survey, but it is :ients subsequently developed secondary unclear whether this patient had diffuse or localised the site of the biopsy wound. In one an lung disease. All the other deaths reported in these inoma had been successfully removed at series occurred in patients with diffuse lung disease. There have however, been two reports of death after biopsy of localised lung lesions with a VimSilverman needle.'7 Both died from haemorrhage. One of the biopsies was performed without screening control and it is clear from the report that three "blind" attempts were made before the patient collapsed. There have also been reports of three patients in whom secondary deposits of tumour developed in the needle track after cutting lung biopsy.6 8 Since 1965 there have been more reports of needle aspiration or screw techniques which produce cytological specimens.20-3 Diagnostic accuracy for malignant lesions ranged from 50% to 96%. After this procedure the pneumothorax rate ranged from 7*5% to 49%, intercostal tubes being required in 1-3-21% of patients; complicating haemorrhage occurred in 0-37% and major haemorrhage in 0-2-1%, and fatal complications were reported in 0-0 69% of patients. Three further fatalities have been reported after aspiration,32--I all three in patients with diffuse pulmonary disease.
All reports of aspiration cytology have emphasised the importance of an expert cytopathologist and yet the concordance of aspiration cytology with definitive histology was generally poor3-37 even for squamous cell carcinoma, the commonest cell type. Most series have contained examples of patients with malignant disease who were incorrectly diagnosed as suffering from benign lesions on the basis of this technique. In four recent series the false negative rate in patients with malignant disease was 4%,30 11%,35 12%,27 and 4-13% (depending on aspiration technique). 38 Another major problem with aspiration techniques was the difficulty of diagnosing benign lesions accurately, even when the material aspirated was examined histologically. 38 We failed to obtain useful material from seven patients, in three of whom the lesion was missed. Of the five patients with lesions less than 2 cm in diameter, we missed the lesion in two and obtained unhelpful histological material in a third. We would now not advise Trucut needle biopsy in this group-a conclusion which supports those of two earlier studies.6 ,s
Non-contributory histological material should be regarded not as reassuring but as representing a failed investigation. Thoracotomy was subsequently advised or would have been advised in four of our patients (table 2) . Development of a cerebellar syndrome in a fifth led to computed tomography, which showed evidence of widespread cerebral and cerebellar metastases. One woman refused further investigation and management was expectant in another because of her age, general condition, and underlying leukaemia.
Complication rates
The complication rates were similar to those reported for cutting needle and aspiration biopsies. Our contraindications to biopsy were based on commonsense and on published recommendations. We believe that the details of our technique were also very important in minimising complications. We collected information prospectively and the accuracy of reporting, especially of haemorrhage, is likely to be greater than in retrospective series. Believing that pneumothoraces are often caused by the local anaesthetic needle, we try to ensure that patients do not breathe whenever any needle is, or could be, near the pleura or when the needle is being moved within the lung.
Metastic deposits in the needle track have been reported more frequently after cutting needle biopsy6 18 19 than after fine needle aspiration.928 With a Trucut needle the specimen is sheathed by the outer needle during withdrawal. Despite this we saw two patients develop secondary deposits at the site of needle penetration, and in one man this was the only evidence of recurrent tumour. Some workers'9 regard a potentially operable carcinoma as a contraindication to cutting needle biopsy. We believe that this advice overstates the case, but certainly the risk of needle track secondaries has to be considered along with the other risks and benefits before a biopsy is advised in such patients. One of our patients with a needle track secondary had an 498 adenocarcinoma and the two patients previously reported whose histological details were recorded also had adenocarcinomas.
Screening control of the procedure must increase diagnostic accuracy and decrease complications. Nevertheless, the rate of extensive or severe haemorrhage was significantly higher in patients with lesions more than 8 cm from the skin surface. Such lesions can nowadays be approached via a fibreoptic bronchoscope with the use ofx ray screening and this technique is safer. Others have conclhded that maximal penetration of the lung should not exceed 3 cm" or 4 cm9 beneath the pleura.
We believe that accurate diagnosis of localised lung disease is important and that Trucut needle biopsy conducted in controlled conditions is a valuable component of the range of biopsy techniques now available. We conclude (table 3) that Trucut needle biopsy of localised intrathoracic lesions is particularly indicated where the lesion is 2 cm or greater in maximum diameter and lies 8 cm or less from the skin surface, because it produces a histological specimen with a higher degree of diagnostic accuracy for both malignant and nonmalignant lesions than do cytological techniques. Lesions less than 2 cm in diameter are better approached with an aspirating needle or Nordenstrom type of needle. Lesions more than 8 cm from the intended biopsy site should be approached via a fibreoptic bronchoscope in the first instance. 
